{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9684943", "DateCompleted": {"Year": "1998", "Month": "10", "Day": "16"}, "DateRevised": {"Year": "2016", "Month": "11", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0176-3679", "JournalIssue": {"Volume": "31 Suppl 1", "PubDate": {"Year": "1998", "Month": "Jun"}}, "Title": "Pharmacopsychiatry", "ISOAbbreviation": "Pharmacopsychiatry"}, "ArticleTitle": "Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.", "Pagination": {"StartPage": "16", "EndPage": "21", "MedlinePgn": "16-21"}, "Abstract": {"AbstractText": ["Hydroalcoholic hypericum extract inhibits the synaptosomal uptake of serotonin, norepinephrine, and dopamine with about similar affinities and leads to a significant down-regulation of cortical beta-adrenoceptors and 5-HT2-receptors after subchronic treatment of rats. While neither hypericine nor kaempferol did show any reuptake inhibiting properties, hyperforin was identified as the unspecific reuptake inhibitor of hypericum extracts with half-maximal inhibitory concentrations for the three synaptosomal uptake systems mentioned above between 80 and 200 nmol/l. Moreover, a hyperforin-enriched (38%) CO2 extract also leads to a significant beta-receptor down-regulation after subchronic treatment. The data suggest hyperforin as the active principle of hypericum extracts in biochemical models of antidepressant activity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Biocenter University of Frankfurt, Germany."}], "LastName": "M\u00fcller", "ForeName": "W E", "Initials": "WE"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Singer", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Wonnemann", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Hafner", "ForeName": "U", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Rolli", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sch\u00e4fer", "ForeName": "C", "Initials": "C"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Pharmacopsychiatry", "NlmUniqueID": "8402938", "ISSNLinking": "0176-3679"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Bridged Bicyclo Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Neurotransmitter Uptake Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Adrenergic, beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Serotonin"}, {"RegistryNumber": "0", "NameOfSubstance": "Terpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Xanthenes"}, {"RegistryNumber": "333DO1RDJY", "NameOfSubstance": "Serotonin"}, {"RegistryNumber": "5QD5427UN7", "NameOfSubstance": "Perylene"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}, {"RegistryNumber": "DHD7FFG6YS", "NameOfSubstance": "Phloroglucinol"}, {"RegistryNumber": "EC 1.4.3.4", "NameOfSubstance": "Monoamine Oxidase"}, {"RegistryNumber": "RM741E34FP", "NameOfSubstance": "hyperforin"}, {"RegistryNumber": "VTD58H1Z2X", "NameOfSubstance": "Dopamine"}, {"RegistryNumber": "X4W3ENH1CV", "NameOfSubstance": "Norepinephrine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "enzymology"], "DescriptorName": "Brain"}, {"QualifierName": [], "DescriptorName": "Bridged Bicyclo Compounds"}, {"QualifierName": ["metabolism"], "DescriptorName": "Dopamine"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Hypericum"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism"], "DescriptorName": "Monoamine Oxidase"}, {"QualifierName": ["chemistry", "metabolism", "pharmacology"], "DescriptorName": "Neurotransmitter Uptake Inhibitors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Norepinephrine"}, {"QualifierName": ["analogs & derivatives", "chemistry", "pharmacology"], "DescriptorName": "Perylene"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Phloroglucinol"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["analogs & derivatives", "chemistry", "pharmacology"], "DescriptorName": "Quercetin"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, Adrenergic, beta"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, Serotonin"}, {"QualifierName": ["metabolism"], "DescriptorName": "Serotonin"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Synaptosomes"}, {"QualifierName": ["analysis", "pharmacology"], "DescriptorName": "Terpenes"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Xanthenes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "7", "Day": "31"}, {"Year": "1998", "Month": "7", "Day": "31", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "7", "Day": "31", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9684943", "10.1055/s-2007-979341"]}}]}